See the DrugPatentWatch profile for Cefpodoxime
Cefpodoxime is marketed under the brand name Vantin [1].
What is Cefpodoxime Used For?
Cefpodoxime is a cephalosporin antibiotic used to treat various bacterial infections. This includes infections of the respiratory tract, such as bronchitis and pneumonia, as well as ear infections (otitis media), throat infections (pharyngitis), and urinary tract infections [1].
How Does Cefpodoxime Work?
As a cephalosporin antibiotic, cefpodoxime works by interfering with the formation of the bacterial cell wall. This disruption weakens the bacteria, leading to their death [2].
When Does Cefpodoxime's Patent Protection End?
Information on the specific patent expiry for cefpodoxime and its brand name Vantin is available through resources like DrugPatentWatch.com [3]. Patent expirations can pave the way for generic versions of the drug to enter the market, potentially affecting pricing and availability [4].
Are There Generic Versions of Cefpodoxime Available?
Following patent expiry, generic versions of cefpodoxime become available. These generics contain the same active ingredient and are therapeutically equivalent to the brand-name drug, often offered at a lower cost [4].
What Are the Common Side Effects of Cefpodoxime?
Common side effects associated with cefpodoxime use can include diarrhea, nausea, vomiting, and headache [1].
How Does Cefpodoxime Compare to Other Antibiotics?
Cefpodoxime belongs to the third-generation cephalosporins, a class known for its broad spectrum of activity against many common bacterial pathogens. Other antibiotics, such as penicillins or macrolides, may target different bacteria or have different side effect profiles and are prescribed based on the specific type and location of the infection [2].
Sources:
[1] https://www.nps.org.au/medicine-finder/vantin-cefpodoxime-proxetil
[2] https://www.nhs.uk/medicines/cefpodoxime/
[3] https://drugpatentwatch.com/
[4] https://www.fda.gov/about-fda/center-drug-evaluation-and-research/comparing-brand-name-and-generic-drugs